Formerly known as Berkeley Lights, Bruker Cellular Analysis® represents the global standard for live single-cell functional characterisation. By leveraging proprietary optofluidic technology, they enable researchers to isolate, culture, and assay individual cells with unprecedented speed and resolution. As the authorised Australian partner, we provide local research institutes and pharmaceutical companies with direct access to these transformative platforms, which are foundational to the Life Science and Diagnostics sector across Australia and New Zealand.

The mission of Bruker Cellular Analysis is to move beyond bulk population averages to uncover the unique functional insights of every cell in real time. Their advanced systems link live-cell imaging and multi-parameter functional assays with downstream genomic analysis, creating a seamless workflow for drug discovery and immunology. We support these sophisticated platforms with the same level of technical excellence found across our broader Bruker portfolio, ensuring your laboratory stays at the forefront of translational research.

Technical Applications for Bruker Cellular Analysis in Australia

In Australian oncology and vaccine research, the ability to rapidly identify high-performing cell clones is a critical technical priority. The Bruker Beacon Discovery Optofluidic System addresses this by enabling the screening of thousands of individual cells in parallel, significantly shortening the timeline for antibody discovery and T-cell profiling. For high-volume environments requiring high-fidelity phenotypic screening, the Bruker Cellular Analysis Optofluidic System Beacon provides robust positive pressure and six-color imaging capabilities.

For researchers bridging the gap between cellular insights and preclinical models, we offer a range of complementary analytical tools. This includes the Bruker Minispec LF50 Body Composition Mice Analyzer for longitudinal studies in small animal models, and the Bruker Fourier ChemLab FT-NMR Benchtop Package for verifying chemical synthesis in the lab. By integrating these high-fidelity single-cell and molecular analysis tools, we help Australian scientists maintain a comprehensive understanding of biological behavior from the microscopic to the macroscopic scale.

Why Source Bruker Cellular Analysis from John Morris Group?

• Revolutionary Optofluidic Platform: Exclusive access to Beacon technology that isolates and assays thousands of live cells simultaneously using light-based manipulation on a microfluidic chip.
• High-Throughput Antibody Discovery: Dramatically accelerates lead candidate selection by identifying top-performing clones in days, providing a significant advantage in biopharma competitive timelines.
• Integrated Proteomic Barcoding: Solutions like Isospark and CodePlex deliver deep, multiplexed protein profiling to uncover the true heterogeneity of cellular populations at scale.
• Seamless Multi-Omic Workflows: Systems are engineered to link functional phenotype data directly to downstream genomic analysis, enabling the recovery of specific cells for sequencing.
• Local Translational Expertise: Backed by over 70 years of experience and factory-trained specialists in Australia and New Zealand for on-site installation, training, and method development.

We combine these world-class single-cell tools with dedicated local support to ensure your facility achieves maximum productivity and scientific impact.

Frequently Asked Questions

What is optofluidic technology and how does it work?
Optofluidics uses light to move individual cells within a microfluidic chip. By creating "light traps," researchers can precisely capture, move, and isolate single cells into individual pens for culturing and assaying without damaging the cell membrane.

How does the Beacon platform improve the antibody discovery process?
Traditional screening can take weeks or months. The Beacon platform identifies the highest-secreting and most specific antibody clones in a single run, allowing researchers to find "the needle in the haystack" much faster than conventional plate-based methods.

Can these systems be used for cell line development (CLD)?
Yes, the technology is ideal for CLD as it provides visual evidence of monoclonality and allows for the early measurement of growth rates and productivity. This ensures that only the best clones are moved forward into scale-up.

What is the benefit of single-cell analysis over bulk population analysis?
Bulk analysis provides an average result that can hide rare but highly important cells, such as elite responders or specific T-cell clones. Single-cell analysis reveals the full spectrum of heterogeneity within a population, which is critical for personalised medicine and immunology.

Is there an upgrade path for standard Bruker TD-NMR systems?
For laboratories focusing on material science or food quality, we provide the Bruker Minispec SFC Analyzer MQ20, which offers upgradeable TD-NMR capabilities for solid fat content and other industrial analyses alongside life science applications.

What local support is available for these sophisticated systems in New Zealand?
Our Auckland-based service centre provides comprehensive support across New Zealand, including specialised training and preventative maintenance. This local presence ensures that your high-throughput cellular analysis workflows remain operational and technically accurate.